Laszlo Bajzar

4.4k total citations · 2 hit papers
38 papers, 3.5k citations indexed

About

Laszlo Bajzar is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Laszlo Bajzar has authored 38 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 12 papers in Cardiology and Cardiovascular Medicine and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Laszlo Bajzar's work include Blood Coagulation and Thrombosis Mechanisms (32 papers), Blood properties and coagulation (11 papers) and Protease and Inhibitor Mechanisms (10 papers). Laszlo Bajzar is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (32 papers), Blood properties and coagulation (11 papers) and Protease and Inhibitor Mechanisms (10 papers). Laszlo Bajzar collaborates with scholars based in Canada, United States and Netherlands. Laszlo Bajzar's co-authors include Michael E. Nesheim, John Morser, Michael B. Boffa, John B. Walker, ME Nesheim, PB Tracy, Wei Wang, Petr Klement, Peng Liao and Paula B. Tracy and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Laszlo Bajzar

38 papers receiving 3.3k citations

Hit Papers

Purification and Characterization of TAFI, a Thrombin-act... 1995 2026 2005 2015 1995 1996 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laszlo Bajzar Canada 27 2.5k 817 707 649 563 38 3.5k
Victor Gurewich United States 32 1.5k 0.6× 864 1.1× 1.0k 1.4× 1.0k 1.6× 559 1.0× 144 4.0k
Amparo Estellés Spain 31 1.1k 0.4× 398 0.5× 352 0.5× 477 0.7× 294 0.5× 84 2.5k
Antonio Ordinas Spain 35 2.1k 0.8× 629 0.8× 649 0.9× 139 0.2× 365 0.6× 173 3.6k
D C Stump United States 33 1.0k 0.4× 1.2k 1.4× 716 1.0× 701 1.1× 287 0.5× 67 3.1k
Kellie R. Machlus United States 26 1.7k 0.7× 370 0.5× 562 0.8× 148 0.2× 673 1.2× 70 3.0k
Peter C. Harpel United States 25 964 0.4× 273 0.3× 431 0.6× 420 0.6× 599 1.1× 46 2.8k
Fabrizio Semeraro Italy 19 820 0.3× 287 0.4× 480 0.7× 216 0.3× 812 1.4× 35 3.4k
Elena M. Faioni Italy 22 1.7k 0.7× 537 0.7× 219 0.3× 95 0.1× 254 0.5× 66 2.3k
Bruce M. Ewenstein United States 49 4.7k 1.8× 552 0.7× 202 0.3× 125 0.2× 1.3k 2.3× 149 6.9k
J. Vermylen Belgium 31 1.1k 0.4× 486 0.6× 455 0.6× 132 0.2× 211 0.4× 110 2.6k

Countries citing papers authored by Laszlo Bajzar

Since Specialization
Citations

This map shows the geographic impact of Laszlo Bajzar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laszlo Bajzar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laszlo Bajzar more than expected).

Fields of papers citing papers by Laszlo Bajzar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laszlo Bajzar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laszlo Bajzar. The network helps show where Laszlo Bajzar may publish in the future.

Co-authorship network of co-authors of Laszlo Bajzar

This figure shows the co-authorship network connecting the top 25 collaborators of Laszlo Bajzar. A scholar is included among the top collaborators of Laszlo Bajzar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laszlo Bajzar. Laszlo Bajzar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauman, Mary, Keith L. Black, Aisha Bruce, et al.. (2010). EMPoWarMENT: Edmonton Pediatric Warfarin Self-Management Pilot Study in Children with Primarily Cardiac Disease. Thrombosis Research. 126(2). e110–e115. 28 indexed citations
2.
Bauman, Mary, et al.. (2010). Warfarin induced coagulopathy in children: assessment of a conservative approach. Archives of Disease in Childhood. 96(2). 164–167. 1 indexed citations
3.
Massicotte, M. Patricia, et al.. (2008). Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin. Thrombosis and Haemostasis. 99(6). 1097–1103. 55 indexed citations
4.
Bauman, Mary, Keith L. Black, Stefan Kuhle, et al.. (2008). KIDCLOT©: The importance of validated educational intervention for optimal long term warfarin management in children. Thrombosis Research. 123(5). 707–709. 34 indexed citations
5.
Walker, John B., et al.. (2008). Proteolytic cleavage of carboxypeptidase N markedly increases its antifibrinolytic activity. Journal of Thrombosis and Haemostasis. 6(5). 848–855. 15 indexed citations
6.
Walker, John B. & Laszlo Bajzar. (2007). Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors. Journal of Thrombosis and Haemostasis. 5(6). 1257–1264. 9 indexed citations
8.
Bajzar, Laszlo, Anthony K.C. Chan, M. Patricia Massicotte, & Lesley Mitchell. (2006). Thrombosis in children with malignancy. Current Opinion in Pediatrics. 18(1). 1–9. 42 indexed citations
10.
Chan, Anthony K.C., Leslie R. Berry, Jun Li, et al.. (2003). Overexpression of the 78-kDa Glucose-regulated Protein/Immunoglobulin-binding Protein (GRP78/BiP) Inhibits Tissue Factor Procoagulant Activity. Journal of Biological Chemistry. 278(19). 17438–17447. 48 indexed citations
11.
Walker, John B., Bernadette Hughes, Ian James, et al.. (2003). Stabilization Versus Inhibition of TAFIa by Competitive Inhibitors in Vitro. Journal of Biological Chemistry. 278(11). 8913–8921. 51 indexed citations
12.
Boskovic, Danilo S., Laszlo Bajzar, & Michael E. Nesheim. (2001). Channeling During Prothrombin Activation. Journal of Biological Chemistry. 276(31). 28686–28693. 26 indexed citations
13.
Nesheim, Michael E., John C. Walker, Wei Wang, et al.. (2001). Modulation of Fibrin Cofactor Activity in Plasminogen Activation. Annals of the New York Academy of Sciences. 936(1). 247–260. 14 indexed citations
14.
Stewart, R. J. C., James C. Fredenburgh, Janice Rischke, Laszlo Bajzar, & Jeffrey I. Weitz. (2000). Thrombin-activable Fibrinolysis Inhibitor Attenuates (DD)E-mediated Stimulation of Plasminogen Activation by Reducing the Affinity of (DD)E for Tissue Plasminogen Activator. Journal of Biological Chemistry. 275(47). 36612–36620. 26 indexed citations
15.
Bajzar, Laszlo, Michael E. Nesheim, John Morser, & Paula B. Tracy. (1998). Both Cellular and Soluble Forms of Thrombomodulin Inhibit Fibrinolysis by Potentiating the Activation of Thrombin-activable Fibrinolysis Inhibitor. Journal of Biological Chemistry. 273(5). 2792–2798. 88 indexed citations
16.
Wang, Wei, Michael B. Boffa, Laszlo Bajzar, John B. Walker, & Michael E. Nesheim. (1998). A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis Inhibitor. Journal of Biological Chemistry. 273(42). 27176–27181. 309 indexed citations
17.
Borne, Peter A. von dem, Laszlo Bajzar, Joost C.M. Meijers, Michael E. Nesheim, & Bonno N. Bouma. (1997). Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.. Journal of Clinical Investigation. 99(10). 2323–2327. 189 indexed citations
18.
Bajzar, Laszlo, Michael Kalafatis, Paolo Simioni, & Paula B. Tracy. (1996). An Antifibrinolytic Mechanism Describing the Prothrombotic Effect Associated with Factor VLeiden. Journal of Biological Chemistry. 271(38). 22949–22952. 70 indexed citations
19.
Bajzar, Laszlo, John Morser, & Michael E. Nesheim. (1996). TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex. Journal of Biological Chemistry. 271(28). 16603–16608. 506 indexed citations breakdown →
20.
Bajzar, Laszlo, et al.. (1995). Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor. Journal of Biological Chemistry. 270(24). 14477–14484. 534 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026